Sinopharm Tech Holdings Limited (HKG:8156)
Hong Kong · Delayed Price · Currency is HKD 0.1980
-0.0110 (-5.26%)
Sep 23, 2026, 4:08 PM HKT
Sinopharm Tech Holdings Income Statement
Financials in millions HKD. Fiscal year is July - June.
Millions HKD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 45.58 | 61.25 | 41.28 | 42.84 | 40.99 | |
Revenue Growth | -25.58% | 48.39% | -3.65% | 4.52% | -47.33% |
Cost of Revenue | 39.16 | 47.02 | 36.26 | 37.37 | 39.22 |
Gross Profit | 6.42 | 14.23 | 5.02 | 5.47 | 1.77 |
Selling, General & Admin | 14.59 | 12.93 | 14.18 | 21.47 | 42.43 |
Operating Expenses | 14.3 | 21.07 | 15.42 | 20.59 | 76.39 |
Operating Income | -7.88 | -6.84 | -10.4 | -15.12 | -74.62 |
Interest Expense | -4.01 | -5.85 | -23.93 | -8.57 | -16.41 |
Interest & Investment Income | 0 | 0 | 0.08 | 0 | 0 |
Earnings From Equity Investments | - | - | - | 0.19 | -0.15 |
Other Non Operating Income (Expenses) | 0.19 | -0.29 | 0.26 | 31.19 | 3.84 |
EBT Excluding Unusual Items | -11.69 | -12.97 | -33.99 | 7.68 | -87.34 |
Impairment of Goodwill | - | - | - | - | -12.31 |
Gain (Loss) on Sale of Investments | - | 1.1 | -2.73 | -18.53 | -21.89 |
Gain (Loss) on Sale of Assets | 0 | 6.93 | 16.56 | - | 8.69 |
Asset Writedown | - | - | - | - | -8.13 |
Other Unusual Items | - | 3.86 | -0.16 | - | 26.82 |
Pretax Income | -11.69 | -1.08 | -20.33 | -10.85 | -94.16 |
Income Tax Expense | 0.21 | 0.29 | 0.08 | -1.31 | -0.39 |
Earnings From Continuing Operations | -11.9 | -1.37 | -20.42 | -9.54 | -93.77 |
Earnings From Discontinued Operations | - | - | 0.39 | -0.56 | - |
Net Income to Company | -11.9 | -1.37 | -20.03 | -10.1 | -93.77 |
Minority Interest in Earnings | 2.76 | 0.5 | 0.33 | -0.54 | 5.77 |
Net Income | -9.14 | -0.87 | -19.7 | -10.64 | -88 |
Net Income to Common | -9.14 | -0.87 | -19.7 | -10.64 | -88 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 634 | 465 | 184 | 183 | 180 |
Shares Outstanding (Diluted) | 634 | 465 | 184 | 183 | 180 |
Shares Change | 36.34% | 153.03% | 0.45% | 1.66% | 4.59% |
EPS (Basic) | -0.01 | -0.00 | -0.11 | -0.06 | -0.49 |
EPS (Diluted) | -0.01 | -0.00 | -0.11 | -0.06 | -0.49 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -4.02 | -5.7 | -12.58 | 4.73 | -36.89 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.07 | 0.03 | -0.20 |
Gross Margin | 14.09% | 23.23% | 12.16% | 12.77% | 4.32% |
Operating Margin | -17.28% | -11.16% | -25.20% | -35.29% | -182.06% |
Profit Margin | -20.06% | -1.42% | -47.72% | -24.83% | -214.71% |
Free Cash Flow Margin | -8.82% | -9.30% | -30.48% | 11.05% | -90.00% |
EBITDA | -7.19 | -6.12 | -9.76 | -13.91 | -73.3 |
EBITDA Margin | -15.77% | -9.99% | -23.66% | -32.48% | -178.84% |
D&A For EBITDA | 0.69 | 0.72 | 0.64 | 1.21 | 1.32 |
EBIT | -7.88 | -6.84 | -10.4 | -15.12 | -74.62 |
EBIT Margin | -17.28% | -11.16% | -25.20% | -35.29% | -182.06% |